PTPN11 and lung carcinoma: In the study of lung cancer and cartilage tumors, it was found that through the stimulation of EGF, IL-6, and other growth factors or cytokines, the phosphatase domain of SHP2 can activate the RAS signaling pathway and phosphorylate SHP2 after autophosphorylation [16].